Financials

  • Market Capitalization 70.88 M
  • Employee 6
  • Founded 2000
  • CEO Yuichi Iwaki
  • Website www.medicinova.com
  • Headquarter Delaware, United States
  • FIGI BBG000RDP030
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.29
ratio cours/chiffre d'affaires
70.51

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
4081
ANVS
Annovis Bio, Inc. Common Stock
1.74 USD+2.35%-1.69%-1.69%-25.64%74.13 M USD
4084
NRXS
Neuraxis, Inc. Common Stock
5.74 USD-4.17%-7.42%-10.73%+5.71%72.08 M USD
4101
SPRO
Spero Therapeutics, Inc. - Common Stock
1.20 USD-1.64%-1.64%+1.69%-41.75%69.88 M USD
4106
CSBR
Champions Oncology, Inc. - Common Stock
5.00 USD0.00%+1.21%-4.94%-29.38%69.47 M USD

Nouvelles